scholarly journals Nutritional status is the major factor affecting grip strength of African HIV patients before and during antiretroviral treatment

2017 ◽  
Vol 22 (10) ◽  
pp. 1302-1313 ◽  
Author(s):  
S. Filteau ◽  
G. PrayGod ◽  
S. L. Woodd ◽  
H. Friis ◽  
D. C. Heimburger ◽  
...  
Keyword(s):  
Nutritional Status ◽  
Grip Strength ◽  
Antiretroviral Treatment ◽  
Hiv Patients

Physical activity and capacity at initiation of antiretroviral treatment in HIV patients in Ethiopia

2014 ◽  
Vol 143 (5) ◽  
pp. 1048-1058 ◽  
Author(s):  
M. F. OLSEN ◽  
P. KÆSTEL ◽  
M. TESFAYE ◽  
A. ABDISSA ◽  
D. YILMA ◽  
...  
Keyword(s):  
Physical Activity ◽  
Heart Rate ◽  
Grip Strength ◽  
Antiretroviral Treatment ◽  
Reference Group ◽  
Physical Capacity ◽  
Activity Levels ◽  
Hiv Patients ◽  
Advanced Hiv Disease ◽  
Hiv Negative

SUMMARYWe described levels of habitual physical activity and physical capacity in HIV patients initiating antiretroviral treatment in Ethiopia and assessed the role of HIV and nutritional indicators on these outcomes. Physical activity energy expenditure (PAEE) and activity levels were measured with combined heart rate and movement sensors. Physical capacity was assessed by grip strength, sleeping heart rate and heart rate economy. Grip strength data was also available from a sex- and age-matched HIV-negative reference group. Median PAEE was 27·9 (interquartile range 17·4–39·8) kJ/kg per day and mean±s.d.grip strength was 23·6 ± 6·7 kg. Advanced HIV disease predicted reduced levels of both physical activity and capacity; e.g. each unit viral load [log(1+copies/ml)] was associated with –15% PAEE (P < 0·001) and –1·0 kg grip strength (P < 0·001). Grip strength was 4·2 kg lower in patients compared to HIV-negative individuals (P < 0·001). Low body mass index (BMI) predicted poor physical activity and capacity independently of HIV status, e.g. BMI <16 was associated with −42% PAEE (P < 0·001) and −6·8 kg grip strength (P < 0·001) compared to BMI ⩾18·5. The study shows that advanced HIV and malnutrition are associated with considerably lower levels of physical activity and capacity in patients at initiation of antiretroviral treatment.

Hand grip strength: Outcome predictor and marker of nutritional status

2011 ◽  
Vol 30 (2) ◽  
pp. 135-142 ◽  
Author(s):  
Kristina Norman ◽  
Nicole Stobäus ◽  
M. Cristina Gonzalez ◽  
Jörg-Dieter Schulzke ◽  
Matthias Pirlich
Keyword(s):  
Nutritional Status ◽  
Grip Strength ◽  
Hand Grip Strength ◽  
Outcome Predictor ◽  
Hand Grip

scholarly journals Design and validation of a predictive model for 1-year hospital admission in HIV patients on antiretroviral treatment

2016 ◽  
Vol 23 (4) ◽  
pp. 224-227
Author(s):  
Inés Montes-Escalante ◽  
Patricia Monje-Agudo ◽  
Elena Calvo-Cidoncha ◽  
Carmen V Almeida-González ◽  
Ramón Morillo-Verdugo
Keyword(s):  
Hospital Admission ◽  
Predictive Model ◽  
Antiretroviral Treatment ◽  
Hiv Patients

scholarly journals Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment

2021 ◽  
Author(s):  
María Ema Molas ◽  
Hernando Knobel ◽  
Olivia Ferrández ◽  
Marta de Antonio Cuscó ◽  
Nuria Carballo Martínez ◽  
...  
Keyword(s):  
Community Pharmacy ◽  
Pharmaceutical Care ◽  
Antiretroviral Treatment ◽  
Cross Sectional Study ◽  
Hiv Patients ◽  
Cross Sectional ◽  
Health Crisis ◽  
Plasma Viraemia ◽  
Degree Of Satisfaction ◽  
Cd4 Lymphocyte

Background. The health crisis due to the COVID-19 pandemic is a challenge in the dispensing of outpatient hospital medication (OHM). Models of Antiretroviral Therapy (ART) based on community pharmacy support (ARTCP) have proven to be successful. The aim was to evaluate the degree of satisfaction, acceptability and limitations of the implementation of ARTCP, in the context of a pandemic, in our environment. Methods. Descriptive cross-sectional study carried out in a Barcelona hospital, during the months of July-November 2020. A telephone survey was carried out via a questionnaire on the quality dimensions of the model (degree of satisfaction, acceptability) and associated inconveniences. Data collected: demographics, antiretroviral treatment (ART), concomitant medication, drug interactions (DDIs), CD4 lymphocyte count and plasma viraemia. Data analysis included descriptive statistics. Results. A total of 533 (78.0%) HIV patients receiving ART were included. 71.9% (383/533) of these patients were very satisfied and 76.2% preferred attending the community pharmacy rather than the hospital. The mean satisfaction rating was 9.3 (DS: 1.4). The benefits reported were: 1) proximity to home (406: 76.1%); 2) lower risk of contagion of COVID-19 (318: 59.7%); 3) shorter waiting time (201: 37.1%); 4) time flexibility (104: 19.5%); 5) reduction of financial expenses (35: 6.57%). A total of 11 (2%) patients reported no benefit. Only 22.9% reported disadvantages associated with ARTCP: 1) lack of privacy (65: 12.2%); 2) lack of coordinationorganization (57: 10.7%). Conclusion. The COVID-19 pandemic has had an impact on the provision of pharmaceutical care for HIV patients. The ARTPC model has proved efficient, with patients reporting a high degree of satisfaction.

scholarly journals Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors

ISRN AIDS ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Assane Diouf ◽  
Amandine Cournil ◽  
Khadidiatou Ba-Fall ◽  
Ndèye Fatou Ngom-Guèye ◽  
Sabrina Eymard-Duvernay ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Antiretroviral Treatment ◽  
Cross Sectional Study ◽  
Older Age ◽  
World Health ◽  
Resource Constrained ◽  
Hiv Patients ◽  
Cross Sectional

Cardiovascular risk factors in people on antiretroviral treatment (ART) are poorly documented in resource-constrained settings. A cross-sectional study was conducted in 2009 to assess prevalence of diabetes and hypertension in a sample of 242 HIV-infected patients who had initiated ART between 1998 and 2002 in Dakar, Senegal (ANRS 1215 observational cohort). World Health Organization (WHO) criteria were applied to diagnose diabetes and hypertension. Multiple logistic regressions were used to identify factors associated with diabetes and hypertension. Patients had a median age of 46 years and had received ART for a median duration of about 9 years. 14.5% had diabetes and 28.1% had hypertension. Long duration of ART (≥119 months), older age, higher body mass index (BMI), and higher levels of total cholesterol were associated with higher risks of diabetes. Older age, higher BMI at ART initiation, and higher levels of triglycerides were associated with higher risk of hypertension. This study shows that diabetes and hypertension were frequent in these Senegalese HIV patients on ART. It confirms the association between duration of ART and diabetes and highlights the need to implement programs for prevention of cardiovascular risk factors in HIV patients from resource-constrained settings.

PS-034 Hypophosphatemia in HIV patients treated with antiretroviral treatment

2015 ◽  
Vol 22 (Suppl 1) ◽  
pp. A149.3-A150
Author(s):  
MA Pedrosa Naudín ◽  
E Briones Cuesta ◽  
CJ Dueñas Gutierrez ◽  
M Güemes Garcia ◽  
MA Machín Morón
Keyword(s):  
Antiretroviral Treatment ◽  
Hiv Patients

scholarly journals Suboptimal Immune Reconstitution among HIV-Infected Saudi Patients following Successful Antiretroviral Treatment

2019 ◽  
Vol 2019 ◽  
pp. 1-8
Author(s):  
Fahad Al-Majid ◽  
Zahid Shakoor ◽  
Mazin Barry
Keyword(s):  
Viral Load ◽  
Immune Reconstitution ◽  
Antiretroviral Treatment ◽  
Population Expansion ◽  
Hiv Viral Load ◽  
Hiv Patients ◽  
Delayed Treatment ◽  
Hla Dr ◽  
Before And After ◽  
Saudi Patients

Background and Objectives. Variations in immune reconstitution following antiretroviral treatment (ART) among HIV patients have previously been observed. This study aims at assessing immune reconstitution after successful ART among HIV-infected Saudi patients.Methods. This retrospective study of 240 HIV-infected patients was performed between May 2010 and June 2015 in the HIV center at King Saud Hospital, Riyadh. Data were extracted for CD4, CD8 cell, and CD3/HLA-DR counts along with the viral load from patient records before and after four years of successful ART. The inclusion criterion was patients with CD4 reconstitution of either equal to or more than 400 cells/mm3with an undetectable HIV viral load following ART. Based on their presentation, the HIV patients were grouped into early treatment (ET) and delayed treatment (DT) groups with CD4 counts of 200–350 cells/mm3and less than 200 cells/mm3, respectively.Findings. The pretreatment CD8+ counts of median 865 cells/mm3(interquartile range (IQR) 774–1072) in the DT group declined to median 753 cells/mm3(IQR 574–987;p<0.0001). Moreover, there was a decline in CD8 counts from 703 cells/mm3(IQR 655–747) to 620 cells/mm3(IQR 563–645;p<0.04) in the ET group after four years of successful ART. Pretreatment activation marker (CD3/HLA-DR+) expression of median 29% in the DT group declined to 22% and in the ET group from a median of 23% to 19% after treatment. The CD4/CD8 ratio in the DT group increased from 0.14 (IQR 0.09–0.88) to 0.71 (IQR 0.54–0.9) and from 0.42 (IQR 0.35–0.55) to 0.87 (IQR 0.71–0.98) in the ET group.Conclusion. Immune reconstitution after successful ART among HIV-infected Saudi patients was associated with a CD8 T-cell population expansion with a suboptimal CD4/CD8 ratio and persistent immune activation. Early initiation of ART appears to favorably influence the CD4/CD8 ratio.

Sign in / Sign up

Export Citation Format

Share Document